When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
VIVO - Meridian Bioscience receives NIH funding for COVID-19 molecular test
Meridian Bioscience Inc.
Meridian Bioscience ([[VIVO]] -3.3%) has been awarded funding of ~$1M by the National Institute of Health ((NIH)) Rapid Acceleration of Diagnostics initiative, to accelerate the launch of the company’s SARS-CoV-2 molecular diagnostic test on the Revogene platform.Recently, the application for Emergency Use Authorization for the Revogene SARS-CoV-2 assay was submitted to the FDA.